Stocksigma LogoStocksigma Logo

3B BlackBio Dx Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 4,828 (+42.4% YoY | +44.2% QoQ) ■ EBITDA: 2,106 (+42.9% YoY | +147.1% QoQ) ■ EBITDA Margin (%): 43.6 (+16 bps YoY | +1817 bps QoQ) ■ PAT: 1,780

3B BlackBio Dx Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

3B BlackBio Dx Ltd · Outcome · 13 Nov 2026, 9:25 pm

3B BlackBio Dx Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 4,828 (+42.4% YoY | +44.2% QoQ) ■ EBITDA: 2,106 (+42.9% YoY | +147.1% QoQ) ■ EBITDA Margin (%): 43.6 (+16 bps YoY | +1817 bps QoQ) ■ PAT: 1,780 (+21.0% YoY | +86.7% QoQ) ■ EPS (INR): 21.0 (+19.8% YoY | +100.7% QoQ) 3B BlackBio Dx Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) Segmental Performance Agrochemicals ■ Revenue: 326 (-6.3% YoY | +127.1% QoQ) ■ EBIT: -6.8 (Profit to Loss YoY | Profit to Loss QoQ) ■ EBIT Margin (%): -2.1 (Profit to Loss YoY | Profit to Loss QoQ) Diagnostic kits ■ Revenue: 4,502 (+48.0% YoY | +40.5% QoQ) ■ EBIT: 2,442 (+26.0% YoY | +83.3% QoQ) ■ EBIT Margin (%): 54.2 (-945 bps YoY | +1269 bps QoQ)

Original exchange filing (PDF)

More announcements from 3B BlackBio Dx Ltd

All 3B BlackBio Dx Ltd announcements